JP2023538524A - スプライシングを調節する組成物 - Google Patents

スプライシングを調節する組成物 Download PDF

Info

Publication number
JP2023538524A
JP2023538524A JP2023508065A JP2023508065A JP2023538524A JP 2023538524 A JP2023538524 A JP 2023538524A JP 2023508065 A JP2023508065 A JP 2023508065A JP 2023508065 A JP2023508065 A JP 2023508065A JP 2023538524 A JP2023538524 A JP 2023538524A
Authority
JP
Japan
Prior art keywords
compound
formula
methyl
fluoro
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023508065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538524A5 (https=
Inventor
ルッツィオ，マイケル
ルーカス，ブライアン
ワン，ティアンシェン
Original Assignee
スカイホーク・セラピューティクス・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スカイホーク・セラピューティクス・インコーポレーテッド filed Critical スカイホーク・セラピューティクス・インコーポレーテッド
Publication of JP2023538524A publication Critical patent/JP2023538524A/ja
Publication of JP2023538524A5 publication Critical patent/JP2023538524A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2023508065A 2020-08-05 2021-08-04 スプライシングを調節する組成物 Pending JP2023538524A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063061742P 2020-08-05 2020-08-05
US63/061,742 2020-08-05
PCT/US2021/044528 WO2022031838A1 (en) 2020-08-05 2021-08-04 Compositions for modulating splicing

Publications (2)

Publication Number Publication Date
JP2023538524A true JP2023538524A (ja) 2023-09-08
JP2023538524A5 JP2023538524A5 (https=) 2024-08-13

Family

ID=80117649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023508065A Pending JP2023538524A (ja) 2020-08-05 2021-08-04 スプライシングを調節する組成物

Country Status (13)

Country Link
US (1) US20230331718A1 (https=)
EP (1) EP4192454B1 (https=)
JP (1) JP2023538524A (https=)
KR (1) KR20230048106A (https=)
CN (1) CN116171153B (https=)
AR (1) AR123150A1 (https=)
AU (1) AU2021320763A1 (https=)
CA (1) CA3188104A1 (https=)
IL (1) IL300352A (https=)
MX (1) MX2023001558A (https=)
TW (1) TW202216697A (https=)
UY (1) UY39368A (https=)
WO (1) WO2022031838A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024525275A (ja) * 2021-05-13 2024-07-12 アデックス ファーマ ソシエテ アノニム Ｍｇｌｕ７受容体のネガティブアロステリックモジュレーターとしての置換ヘテロ脂環式誘導体

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020163248A1 (en) 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
EP3920915A4 (en) * 2019-02-05 2022-10-05 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATING SPLICE
CN114126613A (zh) 2019-02-05 2022-03-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
WO2020163544A1 (en) 2019-02-06 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
CN113661162A (zh) 2019-02-06 2021-11-16 斯基霍克疗法公司 用于调节剪接的方法和组合物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019028440A1 (en) * 2017-08-04 2019-02-07 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATING SPLICING
WO2019191229A1 (en) * 2018-03-27 2019-10-03 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
WO2019199972A1 (en) * 2018-04-10 2019-10-17 Skyhawk Therapeutics, Inc. Compounds for the treatment of cancer
JP2022519311A (ja) * 2019-02-05 2022-03-22 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
JP2022519636A (ja) * 2019-02-04 2022-03-24 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
JP7603592B2 (ja) * 2019-02-05 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2579949T3 (es) 2010-02-05 2016-08-17 Heptares Therapeutics Limited Derivados de 1,2,4-triazin-4-amina
WO2022031998A2 (en) 2020-08-05 2022-02-10 Skyhawk Therapeutics, Inc. Process for the preparation of intermediates useful in the preparation of compounds that modulate splicing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019028440A1 (en) * 2017-08-04 2019-02-07 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATING SPLICING
WO2019191229A1 (en) * 2018-03-27 2019-10-03 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
WO2019199972A1 (en) * 2018-04-10 2019-10-17 Skyhawk Therapeutics, Inc. Compounds for the treatment of cancer
JP2022519636A (ja) * 2019-02-04 2022-03-24 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
JP2022519311A (ja) * 2019-02-05 2022-03-22 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
JP7603592B2 (ja) * 2019-02-05 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024525275A (ja) * 2021-05-13 2024-07-12 アデックス ファーマ ソシエテ アノニム Ｍｇｌｕ７受容体のネガティブアロステリックモジュレーターとしての置換ヘテロ脂環式誘導体

Also Published As

Publication number Publication date
AR123150A1 (es) 2022-11-02
IL300352A (en) 2023-04-01
CN116171153A (zh) 2023-05-26
US20230331718A1 (en) 2023-10-19
WO2022031838A1 (en) 2022-02-10
CN116171153B (zh) 2025-11-21
EP4192454A4 (en) 2024-09-11
EP4192454A1 (en) 2023-06-14
TW202216697A (zh) 2022-05-01
CA3188104A1 (en) 2022-02-10
UY39368A (es) 2022-01-31
KR20230048106A (ko) 2023-04-10
MX2023001558A (es) 2023-04-26
AU2021320763A1 (en) 2023-03-30
EP4192454B1 (en) 2026-04-22

Similar Documents

Publication Publication Date Title
JP2023538524A (ja) スプライシングを調節する組成物
US10138249B2 (en) Triazolopyridines and triazolopyrazines as LSD1 inhibitors
US10968221B2 (en) Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
EP3290407B1 (en) Bromodomain inhibitors
WO2022060951A1 (en) Compositions for modulating splicing
EP3392244A1 (en) Cyclopropylamines as lsd1 inhibitors
CA2729220A1 (en) Di-substituted phenyl compounds
WO2023081859A1 (en) Triazine amino derivatives for treating sca3
WO2022060943A1 (en) Compositions for modulating splicing
CN116568302A (zh) 杂环取代的稠合γ-咔啉类衍生物、其制备方法、中间体及应用
CN111518020A (zh) Magl抑制剂及其制备方法、用途
CN112088003A (zh) 制备嘧啶基-4-氨基吡唑化合物的工艺
JP2023538405A (ja) 新規ｎ－複素環ｂｅｔブロモドメイン阻害剤、その調製方法及び医薬応用
WO2022060944A1 (en) Compositions for modulating splicing
CN116249691B (zh) 双环类衍生物调节剂、其制备方法和应用
CN105130884A (zh) 5-甲基-2(1h)吡啶酮衍生物及其制备方法和用途
CN116478147A (zh) 抑制rna解旋酶dhx33活性的氘代化合物、合成方法、药物组合物及用途
CN115611890B (zh) 一种新型噻吩类bet溴结构域抑制剂、其制备方法及医药用途
CN114163446B (zh) 一种喹啉酮骨架的pde4抑制剂及其制备方法与应用
JP2026506166A (ja) ｍｉＲ－１２４誘導剤及びその調製方法及び用途
CN118852164A (zh) Parp选择性抑制剂
CN118027024A (zh) 吡啶并[1,2-a]嘧啶-4-酮衍生物及其制备方法和用途
WO2023220433A1 (en) Compositions useful for modulating splicing
CN121591744A (zh) miR-124诱导剂及其制备方法和用途
JP2025508110A (ja) ピリド［１，２－ａ］ピリミジン－４－オン誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240802

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240802

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250619

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250619

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250708

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260421